A new study published by a group of researchers, including Matthew Johnson from Johns Hopkins, looks at emotionally painful, shame-related processes with psychedelic use.
The surveys collected data from 679 adults planning to use psilocybin before and after psilocybin use. Shame and feelings of guilt were collected using validated reporting measures and assessed alongside other measurements of psychological health.
Results: Most users (89.7%) described their experience of psilocybin as positive, though acute feelings of shame or guilt were commonly reported (68.2% of users) and were difficult to predict. Psilocybin on average produced a small but significant decrease in trait shame that was maintained 2-3 months after use. Trait shame did increase in a large minority (29.8%) of participants.
See the complete study here:
Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use
